Deanol is commonly referred to as 2-(dimethylamino)ethanol, dimethylaminoethanol (DMAE) or dimethylethanolamine (DMEA). It holds tertiary amine and primary alcohol groups as functional groups. Deanol has been used in the treatment of attention deficit-hyperactivity disorder (ADHD), Alzheimer's disease, autism, and tardive dyskinesia. It has been also used as an ingredient in skin care, and in cognitive function- and mood-enhancing products.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Deanol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Deanol. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Deanol. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Deanol. |
| Hydrocodone | Deanol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Deanol. |
| Magnesium sulfate | The therapeutic efficacy of Deanol can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Deanol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Deanol may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Deanol. |
| Mirtazapine | Deanol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Deanol. |
| Orphenadrine | Deanol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Deanol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Deanol. |
| Pramipexole | Deanol may increase the sedative activities of Pramipexole. |
| Ropinirole | Deanol may increase the sedative activities of Ropinirole. |
| Rotigotine | Deanol may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Deanol. |
| Sodium oxybate | Deanol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Deanol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Deanol. |
| Thalidomide | Deanol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Deanol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Deanol. |
| Dicoumarol | The risk or severity of adverse effects can be increased when Deanol is combined with Dicoumarol. |
| Phenindione | The risk or severity of adverse effects can be increased when Deanol is combined with Phenindione. |
| Warfarin | The risk or severity of adverse effects can be increased when Deanol is combined with Warfarin. |
| Phenprocoumon | The risk or severity of adverse effects can be increased when Deanol is combined with Phenprocoumon. |
| Acenocoumarol | The risk or severity of adverse effects can be increased when Deanol is combined with Acenocoumarol. |
| 4-hydroxycoumarin | The risk or severity of adverse effects can be increased when Deanol is combined with 4-hydroxycoumarin. |
| Coumarin | The risk or severity of adverse effects can be increased when Deanol is combined with Coumarin. |
| (R)-warfarin | The risk or severity of adverse effects can be increased when Deanol is combined with (R)-warfarin. |
| Ethyl biscoumacetate | The risk or severity of adverse effects can be increased when Deanol is combined with Ethyl biscoumacetate. |
| Fluindione | The risk or severity of adverse effects can be increased when Deanol is combined with Fluindione. |
| Clorindione | The risk or severity of adverse effects can be increased when Deanol is combined with Clorindione. |
| Diphenadione | The risk or severity of adverse effects can be increased when Deanol is combined with Diphenadione. |
| Tioclomarol | The risk or severity of adverse effects can be increased when Deanol is combined with Tioclomarol. |
| (S)-Warfarin | The risk or severity of adverse effects can be increased when Deanol is combined with (S)-Warfarin. |
| Ethanol | Deanol may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Deanol may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Deanol. |
| Zimelidine | The risk or severity of adverse effects can be increased when Deanol is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Deanol is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Deanol is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Deanol is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Deanol is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Deanol is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Deanol is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Deanol is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Deanol is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Deanol is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Deanol is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Deanol is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Deanol is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Deanol is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Deanol. |
| Indalpine | The risk or severity of adverse effects can be increased when Deanol is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Deanol is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Deanol is combined with Alaproclate. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Deanol. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Deanol. |
| Zopiclone | The risk or severity of adverse effects can be increased when Deanol is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Deanol. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Deanol. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Deanol. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Deanol. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Deanol. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Deanol. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Deanol. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Deanol. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Deanol. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Deanol. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Deanol. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Deanol. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Deanol. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Deanol. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Deanol. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Deanol. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Deanol. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Deanol. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Deanol. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Deanol. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Deanol. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Deanol. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Deanol. |
| Cetirizine | The risk or severity of CNS depression can be increased when Cetirizine is combined with Deanol. |
| Trimethadione | The risk or severity of CNS depression can be increased when Trimethadione is combined with Deanol. |
| Chlorzoxazone | The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Deanol. |
| Thiethylperazine | The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Deanol. |
| Palonosetron | The risk or severity of CNS depression can be increased when Palonosetron is combined with Deanol. |
| Dexbrompheniramine | The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Deanol. |
| Metocurine iodide | The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Deanol. |
| Secobarbital | The risk or severity of CNS depression can be increased when Secobarbital is combined with Deanol. |
| Methocarbamol | The risk or severity of CNS depression can be increased when Methocarbamol is combined with Deanol. |
| Triprolidine | The risk or severity of CNS depression can be increased when Triprolidine is combined with Deanol. |
| Meperidine | The risk or severity of CNS depression can be increased when Meperidine is combined with Deanol. |
| Metharbital | The risk or severity of CNS depression can be increased when Metharbital is combined with Deanol. |
| Quinine | The risk or severity of CNS depression can be increased when Quinine is combined with Deanol. |
| Methohexital | The risk or severity of CNS depression can be increased when Methohexital is combined with Deanol. |